{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:34:14Z","timestamp":1792251254452,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1007\/bf02982558","type":"journal-article","created":{"date-parts":[[2008,11,3]],"date-time":"2008-11-03T17:29:42Z","timestamp":1225733382000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Upshaw-Schulman Syndrome Revisited: A Concept of Congenital Thrombotic Thrombocytopenic Purpura"],"prefix":"10.1007","volume":"74","author":[{"given":"S.","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. D.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ishizashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Funato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Titani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,7,1]]},"reference":[{"key":"BF02982558_CR1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.V16.1.943.943","volume":"14","author":"I Schulman","year":"1960","unstructured":"Schulman I, Pierce M, Likens A, Currimbhoy Z. Studies on thrombopoiesis. I.A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency.Blood. 1960;14:943\u2013957.","journal-title":"Blood"},{"key":"BF02982558_CR2","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM197806152982407","volume":"298","author":"JD Upshaw","year":"1978","unstructured":"Upshaw JD. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia.N Engl J Med. 1978;298:1350\u20131352.","journal-title":"N Engl J Med."},{"key":"BF02982558_CR3","first-page":"368","volume":"300","author":"S Rennard","year":"1979","unstructured":"Rennard S, Abe S. Decreased cold-insoluble globulin in congenital thrombocytopenia (Upshaw-Schulman syndrome).N Engl J Med. 1979;300:368.","journal-title":"N Engl J Med."},{"key":"BF02982558_CR4","first-page":"1284","volume":"305","author":"S Koizumi","year":"1981","unstructured":"Koizumi S, Miura M, Yamagami M, Horita N, Taniguchi N, Migita S. Upshaw-Schulman syndrome and fibronectin (cold-insoluble globulin).N Engl J Med. 1981;305:1284\u20131285.","journal-title":"N Engl J Med."},{"key":"BF02982558_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJM198204153061516","volume":"306","author":"LT Goodnough","year":"1982","unstructured":"Goodnough LT, Saito H, Ratnoff OD. Fibronectin levels in congenital thrombocytopenia: Schulman\u2019s syndrome.N Engl J Med. 1982;306:938\u2013939.","journal-title":"N Engl J Med."},{"key":"BF02982558_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","volume":"307","author":"JL Moake","year":"1982","unstructured":"Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura.N Engl J Med. 1982;307:1432\u20131435.","journal-title":"N Engl J Med."},{"key":"BF02982558_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ajh.2830170311","volume":"17","author":"M Miura","year":"1984","unstructured":"Miura M, Koizumi S, Nakamura K, et al. Efficiency of several plasma components in a young boy with chronic thrombocytopenia and hemolytic anemia who responds repeatedly to normal plasma infusions.Am J Hematol. 1984;17:307\u2013319.","journal-title":"Am J Hematol."},{"key":"BF02982558_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00043426-198624000-00010","volume":"8","author":"T Hara","year":"1986","unstructured":"Hara T, Kitano A, Kajiwara T, Kondo T, Sakai K, Hamasaki Y. Factor VIII concentrate-responsive thrombocytopenia, hemolytic anemia, and nephropathy: evidence that factor VIII:von Willebrand factor is involved in its pathogenesis.Am J Ped Hematol Oncol. 1986;8:324\u2013328.","journal-title":"Am J Ped Hematol Oncol."},{"key":"BF02982558_CR9","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood.V89.12.4663","volume":"89","author":"M Miura","year":"1997","unstructured":"Miura M, Koizumi S, Miyazaki H. Thrombopoietin in Upshaw-Schulman syndrome.Blood. 1997;89:4663\u20134664.","journal-title":"Blood"},{"key":"BF02982558_CR10","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","volume":"87","author":"M Furlan","year":"1996","unstructured":"Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.Blood. 1996;87:4223\u20134234.","journal-title":"Blood"},{"key":"BF02982558_CR11","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","volume":"87","author":"H-M Tsai","year":"1996","unstructured":"Tsai H-M. Physiological cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.Blood. 1996;87:4235\u20134244.","journal-title":"Blood"},{"key":"BF02982558_CR12","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","volume":"89","author":"M Furlan","year":"1997","unstructured":"Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, L\u00e4mmle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.Blood. 1997;89:3097\u20133103.","journal-title":"Blood"},{"key":"BF02982558_CR13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9258(17)42483-5","volume":"261","author":"Y Fujimura","year":"1986","unstructured":"Fujimura Y, Titani K, Holland L, et al. von Willebrand factor. A reduced and alkylated 52\/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib.J Biol Chem. 1986;261:381\u2013385.","journal-title":"J Biol Chem."},{"key":"BF02982558_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1423-0410.1995.tb02579.x","volume":"68","author":"M Shima","year":"1995","unstructured":"Shima M, Fujimura Y, Nishiyama T, et al. ABO blood group genotype and plasma von Willebrand factor in normal individuals.Vox Sanguinis. 1995;68:236\u2013240.","journal-title":"Vox Sanguinis"},{"key":"BF02982558_CR15","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1172\/JCI109795","volume":"65","author":"ZM Ruggeri","year":"1980","unstructured":"Ruggeri ZM, Zimmerman TS. Variant von Willebrand\u2019s disease: characterization of two subtypes by analysis of multimeric composition of factor VIII\/von Willebrand factor in plasma and platelets.J Clin Invest. 1980;65:1318\u20131325.","journal-title":"J Clin Invest."},{"key":"BF02982558_CR16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1645215","volume":"63","author":"U Budde","year":"1990","unstructured":"Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri ZM, Zimmerman TS. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes.Thromb Haemost. 1990;63:312\u2013315.","journal-title":"Thromb Haemost."},{"key":"BF02982558_CR17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1046\/j.1365-2141.1999.01454.x","volume":"105","author":"S Miura","year":"1999","unstructured":"Miura S, Sakurai Y, Takatsuka H, et al. Total inhibition of high shear stress induced platelet aggregation by homodimeric von Willebrand factor A1-loop fragments.Br J Haematol. 1999;105:1092\u20131100.","journal-title":"Br J Haematol."},{"key":"BF02982558_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1055\/s-0037-1614408","volume":"81","author":"M Furlan","year":"1999","unstructured":"Furlan M, Robles R, Morselli B, Sandoz P, L\u00e4mmle B. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.Thromb Haemost. 1999;81:8\u201313.","journal-title":"Thromb Haemost."},{"key":"BF02982558_CR19","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","volume":"339","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.N Engl J Med. 1998;339:1578\u20131584.","journal-title":"N Engl J Med."},{"key":"BF02982558_CR20","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"H-M Tsai","year":"1998","unstructured":"Tsai H-M, Lian EC-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.N Engl J Med. 1998;339:1585\u20131594.","journal-title":"N Engl J Med."},{"key":"BF02982558_CR21","first-page":"869","volume":"34","author":"CK Kasper","year":"1975","unstructured":"Kasper CK, Aledort LM, Counts RB, et al. A more uniform measurement of factor VIII inhibitors.Thromb Diathesis Haemorrhagica. 1975;34:869\u2013872.","journal-title":"Thromb Diathesis Haemorrhagica"},{"key":"BF02982558_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1442-200X.1995.tb03697.x","volume":"37","author":"M Konno","year":"1995","unstructured":"Konno M, Yoshioka A, Takase T, Imai T. Partial clinical improvement in Upshaw-Schulman syndrome following prostacyclin infusion.Acta Paediatr Japonica. 1995;37:97\u2013100.","journal-title":"Acta Paediatr Japonica"},{"key":"BF02982558_CR23","first-page":"184","volume":"71","author":"Y Rabkin","year":"2000","unstructured":"Rabkin Y, Fradin Z, Zeidman A, Schwartz A, Cohen A, Mittelman M. Chronic relapsing thrombocytopenic purpura with severe neurological manifestations and full recovery.Int J Hematol. 2000;71:184\u2013187.","journal-title":"Int J Hematol."},{"key":"BF02982558_CR24","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1172\/JCI112736","volume":"78","author":"JL Moake","year":"1986","unstructured":"Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.J Clin Invest. 1986;78:1456\u20131461.","journal-title":"J Clin Invest."},{"key":"BF02982558_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1172\/JCI119195","volume":"99","author":"ZM Ruggeri","year":"1997","unstructured":"Ruggeri ZM. von Willebrand factor.J Clin Invest, 1997;99:559\u2013564.","journal-title":"J Clin Invest"},{"key":"BF02982558_CR26","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","volume":"88","author":"CA Siedlecki","year":"1996","unstructured":"Siedlecki CA, Lestini BJ, Kottke-Marchant K, Eppell SJ, Wilson, DL. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor.Blood. 1996;88:2939\u20132950.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02982558\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982558.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982558.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T21:57:04Z","timestamp":1632088624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02982558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["BF02982558"],"URL":"https:\/\/doi.org\/10.1007\/bf02982558","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}